Point72 Asset Management
ANRO icon

Point72 Asset Management’s Alto Neuroscience ANRO Stock Holding History

Point72 Asset Management’s Portfolio ANRO Stock Details ANRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13.3M Sell
502,950
-137
-0% -$3.17K 0.01% 1114
2026
Q1 		$11.3M Sell
503,087
-1,103,867
-69% -$20.5M 0.01% 1158
2025
Q4 		$28.6M Buy
1,606,954
+274,517
+21% +$3.46M 0.03% 681
2025
Q3 		$5.36M Buy
1,332,437
+2,682
+0.2% +$8.89K 0.01% 1043
2025
Q2 		$2.93M Buy
1,329,755
+89,702
+7% +$213K 0.01% 1160
2025
Q1 		$2.68M Sell
1,240,053
-452,100
-27% -$1.62M 0.01% 1150
2024
Q4 		$7.16M Buy
1,692,153
+714,461
+73% +$4.46M 0.02% 827
2024
Q3 		$11.2M Sell
977,692
-72,345
-7% -$885K 0.03% 608
2024
Q2 		$11.2M Sell
1,050,037
-74,963
-7% -$976K 0.03% 566
2024
Q1 		$17.3M Buy
+1,125,000
New +$17.6M 0.04% 497

Other funds holding ANRO

AWG
Alpha Wave Global New York $6.24B AUM 59.73% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SSC
Spruce Street Capital New York $510M AUM
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Point72 Asset Management's ANRO Position: Q2 2026 in Review

Point72 Asset Management reduced its Alto Neuroscience (ANRO) stake by 0.03% in Q2 2026, selling an estimated $3.17K and leaving 502,950 shares worth $13.3M. The position accounts for 0.01% of the portfolio, ranked #1114.

Point72 Asset Management first reported a position in ANRO in Q1 2024 and has held it in 10 quarters since. The position peaked at $28.6M in Q4 2025. 114 funds tracked by Wall St. Rank hold ANRO as of Q2 2026.

  • Point72 Asset Management held 502,950 shares of Alto Neuroscience worth $13.3M as of Q2 2026.
  • Point72 Asset Management sold 137 Alto Neuroscience shares in Q2 2026, an estimated $3.17K.
  • Alto Neuroscience made up 0.01% of Point72 Asset Management's portfolio in Q2 2026, its #1114 holding.
  • Point72 Asset Management first reported a position in Alto Neuroscience in Q1 2024 and has held it in 10 quarters since.
  • Point72 Asset Management's Alto Neuroscience position peaked at $28.6M in Q4 2025.
  • 114 funds tracked by Wall St. Rank held Alto Neuroscience as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.